Le Lézard
Classified in: Health
Subjects: MAV, SHM

/R E P E A T -- MEDIA BRIEFING - 2024 METRO ANNUAL GENERAL MEETING OF SHAREHOLDERS/


MONTREAL, Jan. 17, 2024 /CNW/ - METRO (TSX: MRU) will hold its Annual General Meeting of Shareholders and will announce its results for the first quarter of fiscal year 2024 on Tuesday, January 30, 2024. On this occasion, three virtual events will be held, including a media briefing at 11:30 a.m. 

Information:

Annual General Meeting of Shareholders
Tuesday, January 30, 2024, at 10 a.m.

To access the webcasting platform, click here. Please note that you will only be able to login from 9:45 a.m. on the morning of the event, using the "Guest" function.

Media briefing at 11:30 a.m.

Members of the media are invited to virtually meet with Eric La Flèche, President and CEO, at 11:30 a.m. Please email [email protected] to register and receive the link to access the platform where you will have the opportunity to ask your questions. Please note, this meeting is for media representatives only. Pre-registration is required.

Reminder - Call at 1:30 p.m.

The company will hold a call for investors and financial analysts at 1:30 pm. Click here for more details.

About METRO Inc.

With annual sales of more than $20 billion, METRO Inc. is a food and pharmacy leader in Québec and Ontario, providing employment to more than 97,000 people. Its purpose is to Nourish the health and well-being of our communities. As a retailer, franchisor, distributor, manufacturer, and provider of eCommerce services, the company operates or services a network of some 980 food stores under several banners including Metro, Metro Plus, Super C, Food Basics, Adonis and Première Moisson, and 640 pharmacies primarily under the Jean Coutu, Brunet, Metro Pharmacy and Food Basics Pharmacy banners. For more details, visit corpo.metro.ca.

SOURCE METRO INC.


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: